Skip to main content
NIH funding notice PAR-22-068

Continuation or Revision of NIDCR Clinical Trial Implementation Cooperative Agreement (UH3 Clinical Trial Required)

Closed on January 8, 2025.

Posted
December 1, 2021
Close date
January 8, 2025
Activity codes
UH3
Institutes taking part
NIDCR

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page names no earlier notice: it is new, or it does not say.

Replaced by PAR-25-062.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $637,610 in first-year total cost, median $318,805.

Most frequent study sections

  1. Special Emphasis Panel[ZDE1 YM (02)]2

Most frequent institutions

  1. UNIVERSITY OF CONNECTICUT SCH OF MED/DNT1
  2. UNIVERSITY OF MICHIGAN AT ANN ARBOR1
Competing awards under PAR-22-068 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Individualized Assessment and Treatment Program for TMD: Coping as a Mechanism2UH3DE028520-07LITT, MARK D.UNIVERSITY OF CONNECTICUT SCH OF MED/DNT, CT$557,610ZDE1
2023Phase III RCT of the Effectiveness of Silver Diamine Fluoride in Arresting Cavitated caries Lesions2UH3DE027372-06FONTANA, MARGHERITA RUNIVERSITY OF MICHIGAN AT ANN ARBOR, MI$80,000ZDE1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-22-068: Continuation or Revision of NIDCR Clinical Trial Implementation Cooperative Agreement (UH3 Clinical Trial Required) | ScienceDex | ConductScience